Squarenode

Reliis is a leading Australian drug reformulating company based in Wembley, Western Australia, dedicated to addressing unmet clinical needs through innovative solutions. By collaborating with top clinicians, Reliis accelerates the development of reformulated off-patent medications, offering a more efficient path to registration and commercialisation compared to traditional pharmaceutical approaches. The company's highly experienced leadership and Scientific Advisory Board, composed of renowned clinicians and researchers, enhance their capacity to implement meaningful changes in patient care. Reliis's product pipeline boasts reformulated therapies with global significance, reflecting their commitment to improving healthcare outcomes worldwide. Generated from the website